{"id":"https://openalex.org/W2000351253","doi":"https://doi.org/10.3109/03639045.2012.662511","title":"Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection","display_name":"Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection","alternate_titles":[],"publication_year":2012,"publication_date":"2012-02-13","ids":{"openalex":"https://openalex.org/W2000351253","doi":"https://doi.org/10.3109/03639045.2012.662511","mag":"2000351253","pmid":"https://pubmed.ncbi.nlm.nih.gov/22329865","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3399637"},"language":"en","primary_location":{"id":"doi:10.3109/03639045.2012.662511","doi":"https://doi.org/10.3109/03639045.2012.662511","is_oa":true,"landing_page_url":"https://doi.org/10.3109/03639045.2012.662511","pdf_url":"https://www.tandfonline.com/doi/epdf/10.3109/03639045.2012.662511?needAccess=true&role=button","source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000351253"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/epdf/10.3109/03639045.2012.662511?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047086018","display_name":"John L. Chollet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John L. Chollet","raw_affiliation_strings":["Ther-Rx Corporation, St. Louis, MO 63146, USA. jchollet@Ther-Rx.com","Ther-Rx Corporation, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ther-Rx Corporation, St. Louis, MO 63146, USA. jchollet@Ther-Rx.com","institution_ids":[]},{"raw_affiliation_string":"Ther-Rx Corporation, St. Louis, MO, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048779227","display_name":"Michael J. Jozwiakowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael J. Jozwiakowski","raw_affiliation_strings":["Ther-Rx Corporation, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ther-Rx Corporation, St. Louis, MO, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5047086018"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9184,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.89997774,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"38","issue":"5","first_page":"540","last_page":"549"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydroxyprogesterone-caproate","display_name":"hydroxyprogesterone caproate","score":1.0},{"id":"https://openalex.org/keywords/compounding-pharmacies","display_name":"compounding pharmacies","score":0.7730000019073486},{"id":"https://openalex.org/keywords/impurity-concentration","display_name":"impurity concentration","score":0.48899999260902405},{"id":"https://openalex.org/keywords/drug-potency","display_name":"drug potency","score":0.6940000057220459},{"id":"https://openalex.org/keywords/usp-monograph","display_name":"USP monograph","score":0.6930000185966492},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.5509999990463257},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C207673951","wikidata":"https://www.wikidata.org/wiki/Q1303150","display_name":"Compounding","level":2,"score":0.9111706018447876},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.7709563970565796},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.6483711004257202},{"id":"https://openalex.org/C2780589914","wikidata":"https://www.wikidata.org/wiki/Q10675206","display_name":"Ingredient","level":2,"score":0.5868063569068909},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5374138355255127},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5324500799179077},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4783441722393036},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45616844296455383},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.4493808448314667},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4104255437850952},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.38067758083343506},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24672096967697144},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.08453422784805298},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077713","descriptor_name":"17 alpha-Hydroxyprogesterone Caproate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006908","descriptor_name":"Hydroxyprogesterones","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006908","descriptor_name":"Hydroxyprogesterones","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D006908","descriptor_name":"Hydroxyprogesterones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011372","descriptor_name":"Progestins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011372","descriptor_name":"Progestins","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D011372","descriptor_name":"Progestins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047928","descriptor_name":"Premature Birth","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3109/03639045.2012.662511","doi":"https://doi.org/10.3109/03639045.2012.662511","is_oa":true,"landing_page_url":"https://doi.org/10.3109/03639045.2012.662511","pdf_url":"https://www.tandfonline.com/doi/epdf/10.3109/03639045.2012.662511?needAccess=true&role=button","source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3399637","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3399637/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Dev Ind Pharm","raw_type":"Text"},{"id":"pmid:22329865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22329865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development and industrial pharmacy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3109/03639045.2012.662511","doi":"https://doi.org/10.3109/03639045.2012.662511","is_oa":true,"landing_page_url":"https://doi.org/10.3109/03639045.2012.662511","pdf_url":"https://www.tandfonline.com/doi/epdf/10.3109/03639045.2012.662511?needAccess=true&role=button","source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9074000120162964}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000351253.pdf","grobid_xml":"https://content.openalex.org/works/W2000351253.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W110541726","https://openalex.org/W182806218","https://openalex.org/W1501665473","https://openalex.org/W1585470061","https://openalex.org/W1971064204","https://openalex.org/W1981711985","https://openalex.org/W1982779748","https://openalex.org/W1999729239","https://openalex.org/W2006972239","https://openalex.org/W2013488890","https://openalex.org/W2018286634","https://openalex.org/W2023752972","https://openalex.org/W2044523005","https://openalex.org/W2054527033","https://openalex.org/W2056862635","https://openalex.org/W2057159511","https://openalex.org/W2065614074","https://openalex.org/W2148605209","https://openalex.org/W2151178558","https://openalex.org/W2161047914","https://openalex.org/W2165712919","https://openalex.org/W2187102981","https://openalex.org/W2327473675","https://openalex.org/W2488395786","https://openalex.org/W2596984658","https://openalex.org/W4248981510","https://openalex.org/W4250396314"],"related_works":["https://openalex.org/W2024208503","https://openalex.org/W1987284982","https://openalex.org/W2474889501","https://openalex.org/W2610762036","https://openalex.org/W2068245947","https://openalex.org/W2001339068","https://openalex.org/W2380497900","https://openalex.org/W2390065377","https://openalex.org/W3205723528","https://openalex.org/W2054527033"],"abstract_inverted_index":{"The":[0],"purpose":[1],"of":[2,10,31,39,57,70,89,133,148,171,192,202],"this":[3],"study":[4],"was":[5,115,129],"to":[6,27,35,51,65,117,153],"investigate":[7,36],"the":[8,28,32,37,48,52,71,90,98,105,109,141,155,160,167,172,178,183,190,199],"quality":[9,38],"hydroxyprogesterone":[11],"caproate":[12],"(HPC)":[13],"active":[14],"pharmaceutical":[15],"ingredient":[16],"(API)":[17],"sources":[18],"that":[19,82,127,198],"may":[20],"be":[21,66,119],"used":[22,107],"by":[23,102],"compounding":[24,45,138],"pharmacies,":[25],"compared":[26,50],"FDA-approved":[29,53,184,210],"source":[30,63],"API;":[33],"and":[34,146,196],"HPC":[40,120,134,164,194],"injection":[41,135,165,174],"samples":[42,93,132,150,175],"obtained":[43,60,136],"from":[44,61,137],"pharmacies":[46,139],"in":[47,80,108,159],"US,":[49],"product":[54,212],"(Makena(\u00ae)).":[55],"Samples":[56],"API":[58,92,106,113],"were":[59,77,83,143],"every":[62],"confirmed":[64],"an":[67,204,209],"original":[68],"manufacturer":[69],"drug":[72,185,211],"for":[73,104,163,182],"human":[74],"use,":[75],"which":[76],"all":[78],"companies":[79],"China":[81],"not":[84,96,118,216],"registered":[85],"with":[86],"FDA.":[87],"Eight":[88],"ten":[91],"(80%)":[94],"did":[95],"meet":[97,154],"impurity":[99,179],"specifications":[100],"required":[101],"FDA":[103],"approved":[110],"product.":[111,186],"One":[112],"sample":[114],"found":[116],"at":[121],"all;":[122],"additional":[123],"laboratory":[124],"testing":[125],"showed":[126],"it":[128],"glucose.":[130],"Thirty":[131],"throughout":[140],"US":[142],"also":[144],"tested,":[145],"eight":[147],"these":[149],"(27%)":[151],"failed":[152],"potency":[156],"requirement":[157],"listed":[158],"USP":[161],"monograph":[162],"and/or":[166],"HPLC":[168],"assay.":[169],"Sixteen":[170],"thirty":[173],"(53%)":[176],"exceeded":[177],"limit":[180],"set":[181],"These":[187],"results":[188],"confirm":[189],"inconsistency":[191],"compounded":[193,206],"Injections":[195],"suggest":[197],"risk-benefit":[200],"ratio":[201],"using":[203],"unapproved":[205],"preparation,":[207],"when":[208],"is":[213,215],"available,":[214],"favorable.":[217]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000351253","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
